Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 19, 2023

Clonal Hematopoiesis in the Donor Does Not Adversely Affect Long-Term Outcomes After Allogeneic HSCT



Additional Info

Disclosure statements are available on the authors' profiles:

Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from 13-year followup
Haematologica 2023 Feb 02;[EPub Ahead of Print], KH Kim, T Kim, I Novitzky-Basso, H Lee, Y Yoo, JS Ahn, I Pasic, A Law, W Lam, FV Michelis, A Gerbitz, A Viswabandya, J Lipton, R Kumar, J Mattsson, Z Zhang, N Kaushansky, Y Brilon, N Chapal-Ilani, T Biezuner, LI Shlush, DDH Kim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading